Results 211 to 220 of about 47,298 (270)

Myositis-Myasthenia Overlap Syndrome After Immune Checkpoint Inhibitor Treatment: A Case Report. [PDF]

Cureus
Awad CS, Redick JC, Scheel S, Pohlman N, Khandelwal S, Bischof J.   +5 more
europepmc   +1 more source

Immune checkpoint inhibitors and myocarditis-myositis-myasthenia gravis overlap: a FAERS pharmacovigilance study with time-to-onset characterization. [PDF]

Front Pharmacol
Pacaci B, Yildirim B, Tunc MA, Demirel A, Akagunduz F, Kocaaslan E, Guren AK, Demircan NC, Bayoglu IV.   +8 more
europepmc   +1 more source

Robotic thymectomy in myasthenia gravis: current evidence, outcomes, and future perspective. [PDF]

J Cardiothorac Surg
Huang J, Pan C, He J, Qin J, Liang S, Zhou Y, Zhong Y.   +6 more
europepmc   +1 more source

Triple-M Overlap Syndrome Associated with Immune Checkpoint Inhibitors: A FAERS Pharmacovigilance Analysis. [PDF]

Healthcare (Basel)
Alshamsan B, Ng TL.
europepmc   +1 more source

Sleep disorders in patients with myasthenia gravis based on antibody subtypes: a polysomnographic study. [PDF]

BMC Neurol
Arslan B, Uluc K, Agan K, Koytak PK, Sunter G.   +4 more
europepmc   +1 more source

Bulbar Onset Generalized Myasthenia Gravis in an Elderly Patient: A Diagnostic Challenge. [PDF]

Cureus
Abay B, Mehjeba M, Bajgamage A, Suman S.
europepmc   +1 more source

Assessing respiratory status in myasthenia gravis: limited value of the MG-ADL as a standalone tool compared with spirometry in a Danish cohort. [PDF]

J Neurol
Andersen LK, Birnbaum S, Missel M, Petersen KG, Mohringer C, Deurell E, Witting N, Vissing J.   +7 more
europepmc   +1 more source

Validation and clinical utility of OMGRate and MG-QOL15 in evaluating symptoms and quality of life in Chinese patients with ocular myasthenia gravis. [PDF]

Front Neurol
Tang T, Feng Q, Cai Y, Dong Y, Chen J, Zhang R, Zhou Q.   +6 more
europepmc   +1 more source